CA2481394A1 - Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol - Google Patents

Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol Download PDF

Info

Publication number
CA2481394A1
CA2481394A1 CA002481394A CA2481394A CA2481394A1 CA 2481394 A1 CA2481394 A1 CA 2481394A1 CA 002481394 A CA002481394 A CA 002481394A CA 2481394 A CA2481394 A CA 2481394A CA 2481394 A1 CA2481394 A1 CA 2481394A1
Authority
CA
Canada
Prior art keywords
composition according
ophthalmic composition
gel
diclofenamide
timolol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002481394A
Other languages
English (en)
Inventor
Guenther Bellmann
Gudrun Claus-Herz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Dr Gerhard Mann Chem Pharm Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Gerhard Mann Chem Pharm Fabrik GmbH filed Critical Dr Gerhard Mann Chem Pharm Fabrik GmbH
Publication of CA2481394A1 publication Critical patent/CA2481394A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition ophthalmologique se présentant sous forme de préparation en gel formant des gouttes et contenant de la diclofenamide se présentant sous sa forme libre et du timolol. L'invention concerne également l'utilisation de telles préparations en gel formant des gouttes pour traiter l'hypertension oculaire et les glaucomes à angle ouvert primaires et secondaires.
CA002481394A 2002-05-24 2002-05-24 Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol Abandoned CA2481394A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/005738 WO2003099258A1 (fr) 2002-05-24 2002-05-24 Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol

Publications (1)

Publication Number Publication Date
CA2481394A1 true CA2481394A1 (fr) 2003-12-04

Family

ID=29558277

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002481394A Abandoned CA2481394A1 (fr) 2002-05-24 2002-05-24 Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol

Country Status (4)

Country Link
EP (1) EP1507513A1 (fr)
AU (1) AU2002325220A1 (fr)
CA (1) CA2481394A1 (fr)
WO (1) WO2003099258A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183076B2 (en) 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
USRE49758E1 (en) 2012-01-23 2023-12-19 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
KR101656121B1 (ko) 2010-03-17 2016-09-08 노바리크 게엠베하 안압 증가를 치료하기 위한 약학 조성물
CN104755073B (zh) 2012-09-12 2017-12-26 诺瓦利克有限责任公司 半氟化烷烃组合物
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
BR112020006072A2 (pt) 2017-09-27 2020-10-06 Novaliq Gmbh composições oftalmáticas compreendendo latanoprost para uso no tratamento de doenças oculares
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
WO2019166631A1 (fr) 2018-03-02 2019-09-06 Novaliq Gmbh Compositions pharmaceutiques contenant du nébivolol
MX2020010078A (es) * 2018-03-28 2021-02-26 Novaliq Gmbh Composicion farmaceutica que comprenden timolol.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
ATE9059T1 (de) * 1980-01-28 1984-09-15 Merck & Co. Inc. Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
US4678855A (en) * 1985-10-09 1987-07-07 Merck & Co., Inc. Substituted benzenesulfonamides
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
WO2001052812A1 (fr) * 2000-01-20 2001-07-26 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Gel suspension de diclofenamide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183076B2 (en) 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
USRE49758E1 (en) 2012-01-23 2023-12-19 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes

Also Published As

Publication number Publication date
EP1507513A1 (fr) 2005-02-23
AU2002325220A1 (en) 2003-12-12
WO2003099258A1 (fr) 2003-12-04

Similar Documents

Publication Publication Date Title
US11058684B2 (en) Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
EP2734206A1 (fr) Combinaison à dose fixe de bimatoprost et brimonidine
JP2008532985A (ja) 新規眼科用組成物及びその使用方法
CA2481394A1 (fr) Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol
CN114585365A (zh) 在假晶状体患者中使用拟副交感神经药物单独或与一种或多种α激动剂组合以产生多焦点
WO2021039748A1 (fr) Diquafosol ou sel correspondant et composition ophtalmique aqueuse contenant de la polyvinylpyrrolidone
WO2012149381A1 (fr) Compositions et procédés pour améliorer la vision nocturne
RU2136252C1 (ru) Противовоспалительные глазные капли
CN114502155A (zh) 增强抗老视作用的卡巴胆碱-溴莫尼定制剂
JPH05194271A (ja) 局所眼薬組成物
EP4029493A1 (fr) Composition ophtalmique en nanoémulsion comprenant de la cyclosporine et du menthol, et son procédé de préparation
JP2002316926A (ja) コンタクトレンズ用眼科用組成物及び眼刺激性の緩和方法
GR1009419B (el) Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
JPS6352609B2 (fr)
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
ES2202271T3 (es) Gel de suspension de diclofenamida.
EP0205606B1 (fr) Compositions pharmaceutiques et leur utilisation comme agents mydriatiques
JPH07508745A (ja) （ｓ）−チモロール半水和物を含有する局所眼科治療用組成物及びその製造方法
CA2015657A1 (fr) Compose pharmaceutique
JP5713791B2 (ja) 眼科用剤
JPS6410497B2 (fr)
AU770365B2 (en) The process for manufacturing formulation of topical beta blockers with improved efficacy
WO2018174145A1 (fr) Agent de prévention de la myopie, de traitement de la myopie, et/ou de prévention de la progression de la myopie comprenant de l'uméclidinium en tant que principe actif
EP0375299A1 (fr) Mélanges d'inhibiteurs ACE et CA pour le traitement du glaucome
KR100261585B1 (ko) 항염증점안제

Legal Events

Date Code Title Description
FZDE Discontinued